{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:27:45Z","timestamp":1792697265568,"version":"4.5.0"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.thromres.2017.05.015","type":"journal-article","created":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T22:00:24Z","timestamp":1495058424000},"page":"140-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Venous thromboembolism in the elderly: A narrative review"],"prefix":"10.1016","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8775-0511","authenticated-orcid":false,"given":"T.","family":"Tritschler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Aujesky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.thromres.2017.05.015_bb0005","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2007.02450.x","article-title":"Incidence and mortality of venous thrombosis: a population-based study","volume":"5","author":"Naess","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2017.05.015_bb0010","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1160\/TH08-04-0255","article-title":"Venous thromboembolism in the elderly. A community-based perspective","volume":"100","author":"Spencer","year":"2008","journal-title":"Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.thromres.2017.05.015_bb0015","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.amjmed.2013.02.024","article-title":"Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort","volume":"126","author":"Tagalakis","year":"2013","journal-title":"Am. J. Med."},{"issue":"6","key":"10.1016\/j.thromres.2017.05.015_bb0020","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archinte.160.6.761","article-title":"Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.thromres.2017.05.015_bb0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.clinthera.2014.10.024","article-title":"Inpatient resource use and cost burden of deep vein thrombosis and pulmonary embolism in the United States","volume":"37","author":"LaMori","year":"2015","journal-title":"Clin. Ther."},{"issue":"9","key":"10.1016\/j.thromres.2017.05.015_bb0030","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1182\/blood-2007-06-096545","article-title":"Venous thrombosis in the elderly: more questions than answers","volume":"110","author":"Silverstein","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2017.05.015_bb0035","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/ATVBAHA.108.162461","article-title":"National Heart, Lung, and Blood Institute programs for deep vein thrombosis","volume":"28","author":"Link","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.thromres.2017.05.015_bb0040","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11239-013-0875-2","article-title":"The Swiss cohort of elderly patients with venous thromboembolism (SWITCO65+): rationale and methodology","volume":"36","author":"M\u00e9an","year":"2013","journal-title":"J. Thromb. Thrombolysis"},{"issue":"7","key":"10.1016\/j.thromres.2017.05.015_bb0045","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/CIRCULATIONAHA.110.007864","article-title":"Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation","volume":"124","author":"Poli","year":"2011","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.thromres.2017.05.015_bb0050","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.amjmed.2014.02.011","article-title":"Venous thromboembolism in older adults: A community-based study","volume":"127","author":"Spencer","year":"2014","journal-title":"Am. J. Med."},{"issue":"8","key":"10.1016\/j.thromres.2017.05.015_bb0055","first-page":"1046","article-title":"Venous thromboembolism in very elderly patients: findings from a prospective registry (RIETE)","volume":"91","author":"Lopez-Jimenez","year":"2006","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.thromres.2017.05.015_bb0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/gerona\/62.1.79","article-title":"Frailty and risk of venous thromboembolism in older adults","volume":"62","author":"Folsom","year":"2007","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"7","key":"10.1016\/j.thromres.2017.05.015_bb0065","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/MBC.0b013e3283079e58","article-title":"Risk factors for venous thromboembolism in the elderly: results of the master registry","volume":"19","author":"Ageno","year":"2008","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"7","key":"10.1016\/j.thromres.2017.05.015_bb0070","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/j.1538-7836.2005.01458.x","article-title":"The first ambulatory screening on thromboembolism: a multicentre, cross-sectional, observational study on risk factors for venous thromboembolism","volume":"3","author":"Di Minno","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.thromres.2017.05.015_bb0075","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1111\/j.1538-7836.2010.03986.x","article-title":"Venous thrombosis in the elderly: incidence, risk factors and risk groups","volume":"8","author":"Engbers","year":"2010","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2017.05.015_bb0080","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/jgs.12700","article-title":"Alterations in platelet function during aging: clinical correlations with thromboinflammatory disease in older adults","volume":"62","author":"Mohebali","year":"2014","journal-title":"J. Am. Geriatr. Soc."},{"issue":"8","key":"10.1016\/j.thromres.2017.05.015_bb0085","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0002-9343(02)01345-1","article-title":"Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE)","volume":"113","author":"Tsai","year":"2002","journal-title":"Am. J. Med."},{"issue":"12","key":"10.1016\/j.thromres.2017.05.015_bb0090","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1111\/j.1538-7836.2003.0543b.x","article-title":"High levels of fibrinogen are associated with the risk of deep venous thrombosis mainly in the elderly","volume":"1","author":"van Hylckama Vlieg","year":"2003","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2017.05.015_bb0095","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/archinte.165.3.341","article-title":"Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial","volume":"165","author":"Kucher","year":"2005","journal-title":"Arch. Intern. Med."},{"issue":"9","key":"10.1016\/j.thromres.2017.05.015_bb0100","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/archinte.164.9.963","article-title":"Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX study","volume":"164","author":"Alikhan","year":"2004","journal-title":"Arch. Intern. Med."},{"issue":"4","key":"10.1016\/j.thromres.2017.05.015_bb0105","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/ageing\/aft041","article-title":"Routine pharmacological venous thromboembolism prophylaxis in frail older hospitalised patients: where is the evidence?","volume":"42","author":"Greig","year":"2013","journal-title":"Age Ageing"},{"issue":"1","key":"10.1016\/j.thromres.2017.05.015_bb0110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1378\/chest.09-3081","article-title":"Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators","volume":"139","author":"Decousus","year":"2011","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.thromres.2017.05.015_bb0115","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","article-title":"A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients","volume":"341","author":"Samama","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.thromres.2017.05.015_bb0120","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.CIR.0000138928.83266.24","article-title":"Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients","volume":"110","author":"Leizorovicz","year":"2004","journal-title":"Circulation"},{"issue":"7537","key":"10.1016\/j.thromres.2017.05.015_bb0125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/bmj.38733.466748.7C","article-title":"Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial","volume":"332","author":"Cohen","year":"2006","journal-title":"BMJ"},{"issue":"2 Suppl","key":"10.1016\/j.thromres.2017.05.015_bb0130","doi-asserted-by":"crossref","first-page":"e195S","DOI":"10.1378\/chest.11-2296","article-title":"Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kahn","year":"2012","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.thromres.2017.05.015_bb0135","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1111\/j.1538-7836.2005.01598.x","article-title":"Differential value of risk factors and clinical signs for diagnosing pulmonary embolism according to age","volume":"3","author":"Le Gal","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2017.05.015_bb0140","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11239-013-0942-8","article-title":"Clinical features in patients with pulmonary embolism at a community hospital: analysis of 4 years of data","volume":"37","author":"Bajaj","year":"2014","journal-title":"J. Thromb. Thrombolysis"},{"issue":"4","key":"10.1016\/j.thromres.2017.05.015_bb0145","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/1076029608317942","article-title":"Deep-vein thrombosis in the elderly","volume":"14","author":"Piazza","year":"2008","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"4","key":"10.1016\/j.thromres.2017.05.015_bb0150","first-page":"592","article-title":"High prevalence of asymptomatic deep vein thrombosis on admission in a medical unit among elderly patients","volume":"88","author":"Oger","year":"2002","journal-title":"Thromb. Haemost."},{"issue":"9094","key":"10.1016\/j.thromres.2017.05.015_bb0155","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(97)08140-3","article-title":"Value of assessment of pretest probability of deep-vein thrombosis in clinical management","volume":"350","author":"Wells","year":"1997","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.thromres.2017.05.015_bb0160","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1055\/s-0037-1613830","article-title":"Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer","volume":"83","author":"Wells","year":"2000","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2017.05.015_bb0165","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-144-3-200602070-00004","article-title":"Prediction of pulmonary embolism in the emergency department: the revised Geneva score","volume":"144","author":"Le Gal","year":"2006","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.thromres.2017.05.015_bb0170","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1160\/TH07-05-0321","article-title":"Further validation and simplification of the Wells clinical decision rule in pulmonary embolism","volume":"99","author":"Gibson","year":"2008","journal-title":"Thromb. Haemost."},{"issue":"19","key":"10.1016\/j.thromres.2017.05.015_bb0175","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1001\/archinte.168.19.2131","article-title":"Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism","volume":"168","author":"Klok","year":"2008","journal-title":"Arch. Intern. Med."},{"issue":"2","key":"10.1016\/j.thromres.2017.05.015_bb0180","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.arr.2010.10.005","article-title":"Systematic review: diagnostic accuracy of clinical decision rules for venous thromboembolism in elderly","volume":"10","author":"Siccama","year":"2011","journal-title":"Ageing Res. Rev."},{"issue":"7","key":"10.1016\/j.thromres.2017.05.015_bb0185","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1538-7836.2004.00832.x","article-title":"Effect of age on the assessment of clinical probability of pulmonary embolism by prediction rules","volume":"2","author":"Righini","year":"2004","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2017.05.015_bb0190","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1538-7836.2007.02328.x","article-title":"Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review","volume":"5","author":"Di Nisio","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2017.05.015_bb0195","doi-asserted-by":"crossref","first-page":"448","DOI":"10.7326\/0003-4819-155-7-201110040-00007","article-title":"Clinical decision rules for excluding pulmonary embolism: a meta-analysis","volume":"155","author":"Lucassen","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.thromres.2017.05.015_bb0200","doi-asserted-by":"crossref","first-page":"g1340","DOI":"10.1136\/bmj.g1340","article-title":"Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis","volume":"348","author":"Geersing","year":"2014","journal-title":"BMJ"},{"issue":"2 Suppl","key":"10.1016\/j.thromres.2017.05.015_bb0205","doi-asserted-by":"crossref","first-page":"e351S","DOI":"10.1378\/chest.11-2299","article-title":"Diagnosis of DVT: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.thromres.2017.05.015_bb0210","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0002-9343(00)00493-9","article-title":"Effects of age on the performance of common diagnostic tests for pulmonary embolism","volume":"109","author":"Righini","year":"2000","journal-title":"Am. J. Med."},{"issue":"11","key":"10.1016\/j.thromres.2017.05.015_bb0215","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jama.2014.2135","article-title":"Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study","volume":"311","author":"Righini","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2017.05.015_bb0220","series-title":"Venous Thromboembolic Diseases: The Management of Venous Thromboembolic Diseases and the Role of Thrombophilia Testing, London","author":"National Institute for Health and Clinical Excellence","year":"2012"},{"issue":"2","key":"10.1016\/j.thromres.2017.05.015_bb0225","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1160\/TH03-07-0429","article-title":"Effect of age on the performance of single detector helical computed tomography in suspected pulmonary embolism","volume":"91","author":"Righini","year":"2004","journal-title":"Thromb. Haemost."},{"issue":"43","key":"10.1016\/j.thromres.2017.05.015_bb0230","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/eurheartj\/ehu283","article-title":"2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism","volume":"35","author":"Konstantinides","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2017.05.015_bb0235","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group","year":"2012","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.thromres.2017.05.015_bb0240","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1093\/ndt\/gfw354","article-title":"Prevalence and recognition of chronic kidney disease in Stockholm healthcare","volume":"31","author":"Gasparini","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"10.1016\/j.thromres.2017.05.015_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ajkd.2003.50007","article-title":"Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third national health and nutrition examination survey","volume":"41","author":"Coresh","year":"2003","journal-title":"Am. J. Kidney Dis."},{"issue":"10","key":"10.1016\/j.thromres.2017.05.015_bb0250","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1111\/jth.12701","article-title":"Randomised trial of no hydration vs. sodium bicarbonate hydration in patients with chronic kidney disease undergoing acute computed tomography-pulmonary angiography","volume":"12","author":"Kooiman","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2017.05.015_bb0255","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11239-015-1169-7","article-title":"Clinical significance and management of subsegmental pulmonary embolism","volume":"39","author":"Ikesaka","year":"2015","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.thromres.2017.05.015_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2016.12.005","article-title":"Safety of warfarin in \u201chigh-risk\u201d populations: a meta-analysis of randomized and controlled trials","volume":"150","author":"Di Minno","year":"2017","journal-title":"Thromb. Res."},{"issue":"12","key":"10.1016\/j.thromres.2017.05.015_bb0265","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1182\/blood-2014-04-571232","article-title":"Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials","volume":"124","author":"van Es","year":"2014","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.thromres.2017.05.015_bb0270","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1007\/s00259-009-1170-5","article-title":"EANM guidelines for ventilation\/perfusion scintigraphy: part 1. Pulmonary imaging with ventilation\/perfusion single photon emission tomography","volume":"36","author":"Bajc","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"4","key":"10.1016\/j.thromres.2017.05.015_bb0275","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/oxfordjournals.eurheartj.a015316","article-title":"Clinical epidemiology of venous thromboembolic disease. Results of a french multicentre registry","volume":"18","author":"Ferrari","year":"1997","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.thromres.2017.05.015_bb0280","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra0907731","article-title":"Acute pulmonary embolism","volume":"363","author":"Agnelli","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.thromres.2017.05.015_bb0285","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1182\/blood-2007-11-123711","article-title":"Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based","volume":"111","author":"Levi","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2017.05.015_bb0290","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.thromres.2017.05.015_bb0295","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.amjmed.2005.02.018","article-title":"Oral anticoagulation strategies after a first idiopathic venous thromboembolic event","volume":"118","author":"Aujesky","year":"2005","journal-title":"Am. J. Med."},{"issue":"6","key":"10.1016\/j.thromres.2017.05.015_bb0300","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/jth.12239","article-title":"The predictive ability of bleeding risk stratification models in very old patients on vitamin K antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA study","volume":"11","author":"Poli","year":"2013","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2017.05.015_bb0305","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/jth.12111","article-title":"Prospective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolism","volume":"11","author":"Scherz","year":"2013","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2017.05.015_bb0310","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11606-014-2993-8","article-title":"Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolism","volume":"30","author":"Leiss","year":"2015","journal-title":"J. Gen. Intern. Med."},{"issue":"2","key":"10.1016\/j.thromres.2017.05.015_bb0315","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/jth.12793","article-title":"Physical activity and risk of bleeding in elderly patients taking anticoagulants","volume":"13","author":"Frey","year":"2015","journal-title":"J. Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2017.05.015_bb0320","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.amjmed.2012.01.033","article-title":"Risk of falls and major bleeds in patients on oral anticoagulation therapy","volume":"125","author":"Donze","year":"2012","journal-title":"Am. J. Med."},{"issue":"4","key":"10.1016\/j.thromres.2017.05.015_bb0325","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/joim.12236","article-title":"Risk of falls and bleeding in elderly patients with acute venous thromboembolism","volume":"276","author":"Kampfen","year":"2014","journal-title":"J. Intern. Med."},{"issue":"5","key":"10.1016\/j.thromres.2017.05.015_bb0330","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1503\/cmaj.080493","article-title":"Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy","volume":"179","author":"Rodger","year":"2008","journal-title":"CMAJ"},{"issue":"6","key":"10.1016\/j.thromres.2017.05.015_bb0335","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1538-7836.2012.04735.x","article-title":"Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)","volume":"10","author":"Tosetto","year":"2012","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2017.05.015_bb0340","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000467","article-title":"D-dimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna prediction model","volume":"3","author":"Eichinger","year":"2014","journal-title":"J. Am. Heart Assoc."},{"issue":"16","key":"10.1016\/j.thromres.2017.05.015_bb0345","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1182\/blood-2015-04-641225","article-title":"Predicting recurrence after unprovoked venous thromboembolism: prospective validation of the updated Vienna prediction model","volume":"126","author":"Tritschler","year":"2015","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.thromres.2017.05.015_bb0350","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/jama.2014.10538","article-title":"Clinical and safety outcomes associated with treatment of acute venous thromboembolism: a systematic review and meta-analysis","volume":"312","author":"Castellucci","year":"2014","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.thromres.2017.05.015_bb0355","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1182\/blood-2014-07-590323","article-title":"The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis","volume":"124","author":"Chai-Adisaksopha","year":"2014","journal-title":"Blood"},{"issue":"2 Suppl","key":"10.1016\/j.thromres.2017.05.015_bb0360","doi-asserted-by":"crossref","first-page":"e1S","DOI":"10.1378\/chest.11-2290","article-title":"Patient values and preferences in decision making for antithrombotic therapy: a systematic review: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"MacLean","year":"2012","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.thromres.2017.05.015_bb0365","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.amjmed.2012.12.007","article-title":"Treatment of unstable pulmonary embolism in the elderly and those with comorbid conditions","volume":"126","author":"Stein","year":"2013","journal-title":"Am. J. Med."},{"issue":"23","key":"10.1016\/j.thromres.2017.05.015_bb0370","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1001\/jama.2014.5990","article-title":"Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis","volume":"311","author":"Chatterjee","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.thromres.2017.05.015_bb0375","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.amjmed.2011.06.026","article-title":"Intracerebral hemorrhage with thrombolytic therapy for acute pulmonary embolism","volume":"125","author":"Stein","year":"2012","journal-title":"Am. J. Med."},{"issue":"8","key":"10.1016\/j.thromres.2017.05.015_bb0380","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1161\/01.STR.31.8.1802","article-title":"Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction: results from the cooperative cardiovascular project","volume":"31","author":"Brass","year":"2000","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.thromres.2017.05.015_bb0385","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0749-0690(02)00055-1","article-title":"Diagnosis and treatment of pulmonary embolism in the elderly","volume":"19","author":"Berman","year":"2003","journal-title":"Clin. Geriatr. Med."},{"issue":"2","key":"10.1016\/j.thromres.2017.05.015_bb0390","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jvs.2014.10.036","article-title":"Catheter-directed interventions for acute pulmonary embolism","volume":"61","author":"Avgerinos","year":"2015","journal-title":"J. Vasc. Surg."},{"issue":"15","key":"10.1016\/j.thromres.2017.05.015_bb0395","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa1302097","article-title":"Fibrinolysis for patients with intermediate-risk pulmonary embolism","volume":"370","author":"Meyer","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2017.05.015_bb0400","article-title":"Predictors and causes of long-term mortality in elderly patients with acute venous thromboembolism: a prospective cohort study","author":"Faller","year":"2016","journal-title":"Am. J. Med."},{"issue":"11","key":"10.1016\/j.thromres.2017.05.015_bb0405","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1111\/j.1538-7836.2012.04929.x","article-title":"Prospective comparison of clinical prognostic scores in elder patients with a pulmonary embolism","volume":"10","author":"Zwierzina","year":"2012","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2017.05.015_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155973","article-title":"Comparison of cardiac and non-cardiac biomarkers for risk stratification in elderly patients with non-massive pulmonary embolism","volume":"11","author":"Vuilleumier","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2017.05.015_bb0415","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.thromres.2016.07.014","article-title":"Echocardiography does not predict mortality in hemodynamically stable elderly patients with acute pulmonary embolism","volume":"145","author":"Hofmann","year":"2016","journal-title":"Thromb. Res."},{"issue":"7","key":"10.1016\/j.thromres.2017.05.015_bb0420","doi-asserted-by":"crossref","first-page":"511","DOI":"10.7326\/0003-4819-118-7-199304010-00005","article-title":"Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group","volume":"118","author":"Fihn","year":"1993","journal-title":"Ann. Intern. Med."},{"issue":"10","key":"10.1016\/j.thromres.2017.05.015_bb0425","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archinte.165.10.1095","article-title":"Systematic overview of warfarin and its drug and food interactions","volume":"165","author":"Holbrook","year":"2005","journal-title":"Arch. Intern. Med."},{"issue":"7","key":"10.1016\/j.thromres.2017.05.015_bb0430","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1212\/WNL.55.7.947","article-title":"Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study","volume":"55","author":"Rosand","year":"2000","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.thromres.2017.05.015_bb0435","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1212\/WNL.53.6.1319","article-title":"Stroke Prevention In Reversible Schemia Trial (SPIRIT) and European Atrial Fibrillation Trial (EAFT) study groups, Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors","volume":"53","author":"Gorter","year":"1999","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.thromres.2017.05.015_bb0440","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1532-5415.2006.00828.x","article-title":"Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study","volume":"54","author":"Fang","year":"2006","journal-title":"J. Am. Geriatr. Soc."},{"issue":"4","key":"10.1016\/j.thromres.2017.05.015_bb0445","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/archinte.160.4.470","article-title":"Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study","volume":"160","author":"Palareti","year":"2000","journal-title":"Arch. Intern. Med."},{"issue":"5","key":"10.1016\/j.thromres.2017.05.015_bb0450","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1160\/TH08-06-0390","article-title":"Clinical outcome of patients with major bleeding after venous thromboembolism. Findings from the RIETE Registry","volume":"100","author":"Nieto","year":"2008","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2017.05.015_bb0455","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1538-7836.2006.01795.x","article-title":"Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months","volume":"4","author":"Schulman","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2017.05.015_bb0460","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archinte.160.6.769","article-title":"Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors","volume":"160","author":"Hansson","year":"2000","journal-title":"Arch. Intern. Med."},{"issue":"6","key":"10.1016\/j.thromres.2017.05.015_bb0465","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/MD.0b013e3181c29e31","article-title":"Age at first venous thromboembolism and risk of recurrence: a prospective cohort study","volume":"88","author":"Eischer","year":"2009","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.thromres.2017.05.015_bb0470","doi-asserted-by":"crossref","first-page":"698","DOI":"10.7326\/0003-4819-149-10-200811180-00004","article-title":"Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis","volume":"149","author":"Kahn","year":"2008","journal-title":"Ann. Intern. Med."},{"issue":"18","key":"10.1016\/j.thromres.2017.05.015_bb0475","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000000130","article-title":"The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association","volume":"130","author":"Kahn","year":"2014","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.thromres.2017.05.015_bb0480","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa032274","article-title":"Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism","volume":"350","author":"Pengo","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.thromres.2017.05.015_bb0485","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/jth.13175","article-title":"Derivation of a clinical prediction score for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism","volume":"14","author":"Klok","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2017.05.015_bb0490","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/686011","article-title":"Current concepts in the pathogenesis of chronic thromboembolic pulmonary hypertension","volume":"6","author":"Matthews","year":"2016","journal-title":"Pulm. Circ."},{"issue":"7","key":"10.1016\/j.thromres.2017.05.015_bb0495","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1538-7836.2008.03002.x","article-title":"Determinants of health-related quality of life during the 2 years following deep vein thrombosis","volume":"6","author":"Kahn","year":"2008","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2017.05.015_bb0500","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1378\/chest.09-2482","article-title":"Quality of life in long-term survivors of acute pulmonary embolism","volume":"138","author":"Klok","year":"2010","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.thromres.2017.05.015_bb0505","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.thromres.2013.06.016","article-title":"Quality of life after pulmonary embolism as assessed with SF-36 and PEmb-QoL","volume":"132","author":"van Es","year":"2013","journal-title":"Thromb. Res."},{"issue":"11","key":"10.1016\/j.thromres.2017.05.015_bb0510","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013086","article-title":"Health-related quality of life after pulmonary embolism: a cross-sectional study","volume":"6","author":"Tavoly","year":"2016","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.thromres.2017.05.015_bb0515","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ageing\/30.4.337","article-title":"Using the SF-36 with older adults: a cross-sectional community-based survey","volume":"30","author":"Walters","year":"2001","journal-title":"Age Ageing"},{"issue":"26","key":"10.1016\/j.thromres.2017.05.015_bb0520","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMp1100535","article-title":"Comparative effectiveness research and patients with multiple chronic conditions","volume":"364","author":"Tinetti","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"8824","key":"10.1016\/j.thromres.2017.05.015_bb0525","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0140-6736(92)93285-U","article-title":"Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism","volume":"340","author":"Research Committee of the British Thoracic Society","year":"1992","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.thromres.2017.05.015_bb0530","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1056\/NEJM199506223322501","article-title":"A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism","volume":"332","author":"Schulman","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.thromres.2017.05.015_bb0535","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM199903253401201","article-title":"A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism","volume":"340","author":"Kearon","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.thromres.2017.05.015_bb0540","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1056\/NEJM200107193450302","article-title":"Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis","volume":"345","author":"Agnelli","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.thromres.2017.05.015_bb0545","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa035029","article-title":"Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism","volume":"348","author":"Ridker","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.thromres.2017.05.015_bb0550","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa035422","article-title":"Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism","volume":"349","author":"Kearon","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.thromres.2017.05.015_bb0555","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa0906598","article-title":"Dabigatran versus warfarin in the treatment of acute venous thromboembolism","volume":"361","author":"Schulman","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.thromres.2017.05.015_bb0560","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/CIRCULATIONAHA.113.004450","article-title":"Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis","volume":"129","author":"Schulman","year":"2014","journal-title":"Circulation"},{"issue":"26","key":"10.1016\/j.thromres.2017.05.015_bb0565","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.thromres.2017.05.015_bb0570","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","article-title":"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"Buller","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.thromres.2017.05.015_bb0575","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1302507","article-title":"Oral apixaban for the treatment of acute venous thromboembolism","volume":"369","author":"Agnelli","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.thromres.2017.05.015_bb0580","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1306638","article-title":"Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism","volume":"369","author":"Buller","year":"2013","journal-title":"N. Engl. J. Med."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938481730333X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938481730333X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T06:32:41Z","timestamp":1575613961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938481730333X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":116,"alternative-id":["S004938481730333X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2017.05.015","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Venous thromboembolism in the elderly: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2017.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}